Pro Medicus (ASX:PME) Insider Acquires A$489,240.00 in Stock

Pro Medicus Limited (ASX:PME) insider Sam Hupert purchased 4,500 shares of the stock in a transaction dated Tuesday, February 24th. The stock was acquired at an average cost of A$108.72 per share, for a total transaction of A$489,240.00.

Sam Hupert also recently made the following trade(s):

• On Monday, December 22nd, Sam Hupert acquired 2,250 shares of Pro Medicus stock. The shares were acquired at an average cost of A$221.45 per share, with a total value of A$498,262.50.

Pro Medicus Stock Performance

The company has a market cap of $29.16 billion, a price-to-earnings ratio of 351.99, a P/E/G ratio of 3.87 and a beta of 0.56. The company has a debt-to-equity ratio of 1.10, a current ratio of 5.98 and a quick ratio of 4.39.

Pro Medicus Dividend Announcement

The firm also recently disclosed a Interim dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 19th will be given a $0.32 dividend. This represents a dividend yield of 27.0%. The ex-dividend date of this dividend is Wednesday, February 25th. Pro Medicus’s dividend payout ratio is currently 56.41%.

Pro Medicus Company Profile

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.